共 7 条
- [1] WHAT COURSE OF ACTION SHALL WE TAKE WHEN FINDING A POSITIVE HCV SEROLOGY IN A BLOOD-DONOR [J]. REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1991, 34 (04): : 315 - 342
- [2] WHAT COURSE OF ACTION SHALL WE TAKE WHEN DISCOVERING SYPHILITIC SEROLOGY IN A BLOOD-DONOR [J]. REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1991, 34 (04): : 351 - 352
- [3] WHAT COURSE OF ACTION SHALL WE TAKE WHEN FINDING A POSITIVE HTLV-I/II SEROLOGY IN A BLOOD-DONOR [J]. REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1991, 34 (04): : 305 - 313
- [4] WHAT COURSE OF ACTION SHALL WE TAKE WHEN DISCOVERING LOW HEMATOCRIT OR DECREASED HEMOGLOBIN LEVEL IN A BLOOD-DONOR [J]. REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1991, 34 (04): : 343 - 349
- [5] SPECIAL NUMBER - WHAT COURSE OF ACTION SHOULD BE TAKEN WHEN DISCOVERING A BIOLOGICAL DISORDER IN A BLOOD-DONOR - INTRODUCTION [J]. REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1991, 34 (04): : 281 - 283
- [6] WHAT COURSE OF ACTION SHALL WE TAKE WHEN DISCOVERING SERIC MARKERS OF INFECTION BY THE HEPATITIS-B VIRUS (HBS-ANTIGEN AND OR ANTI-HBC ANTIBODY) - HIGH TRANSAMINASES LEVEL OR BOTH DISORDERS IN A BLOOD-DONOR [J]. REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1991, 34 (04): : 285 - 294